.jpg)
.png)
All
.article-image{ display:inline-block; float:left; padding-right:5px; } Introduction In the late 1980s, the Mediterraneanstyle eating pattern received attention after the results of the Lyon Diet Heart Study were published. More recently, the 2013 American College of Cardiology/ American... more
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are novel, effective oral anti-hyperglycemic medications that inhibit glucose reabsorption in the proximal convoluted tubule of the kidney, independent of insulin, leading to glucosuria and glucose-lowering effects.1 Studies revealed that SGLT2i... more
Greetings from those of us at the Midwest Lipid Association (MWLA). We all trust that you had an excellent summer as we head into cooler weather and color changes up here in the Midwest and Canada. For those of you who do not know, our Canadian partners who are National Lipid Association (NLA)... more
2026 Scientific Sessions Foundations of Lipidology Course (To view the agenda for the February virtual course, click here)
A 37-year-old patient was referred to our lipid clinic from his primary care provider. A basic lipid panel revealed: total cholesterol (TC) 715 mg/dL, triglyceride (TG) 901 mg/dL; HDL-C 45 mg/dL, Lipoprotein(a) [Lp(a)] mass was elevated (44 mg/dL); Lp(a)- cholesterol levels were not measured. The... more
Watch PLA leadership discuss the importance of lipid management and the NLA’s role in advancing cardiometabolic care.
.page-header { display: none; } .btn-about { margin: 10px; } .v-center { display: flex; align-items: flex-start; justify-content: center; flex-grow: 1; width: 390px; } .flex-row { display... more
The National Lipid Association has featured highlights from selected presentations at the 2014 Fall Clinical Lipid Update in Indianapolis. Read our meeting coverage here.
Abstract: The Roundtable in this issue of the journal has to do with a very important topic that has generated much debate and confusion over the years. Do women and men need and receive the same type and intensity of drug therapy to appropriately reduce the incidence of major vascular events?... more